Combining Biologics Targeting Eosinophils (IL-5/IL-5R), IgE, and IL-4/IL-13 in Allergic and Inflammatory Diseases

The indications for biologic therapy are expanding. Patients may benefit from different biologics for separate conditions or one condition with multiple pathogenic mechanisms targeted by different biologics. We sought to determine the frequency and safety of combining biologics targeting IgE, IL-5,...

Descripción completa

Detalles Bibliográficos
Autores principales: Pitlick, Mitchell M., Pongdee, Thanai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: World Allergy Organization 2022
Materias:
Correspondence
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9574495/
https://www.ncbi.nlm.nih.gov/pubmed/36267353
http://dx.doi.org/10.1016/j.waojou.2022.100707

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9574495/
https://www.ncbi.nlm.nih.gov/pubmed/36267353
http://dx.doi.org/10.1016/j.waojou.2022.100707

Ejemplares similares